Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Eye-Tracking System Exposes Brain Health Issues

By HospiMedica International staff writers
Posted on 23 Oct 2018
Print article
Image: Eye movement tracking can help detect neurological issues (Photo courtesy of RightEye).
Image: Eye movement tracking can help detect neurological issues (Photo courtesy of RightEye).
Advanced eye-tracking technology records, views, and analyzes eye movements to help identify visual and brain impairments.

The RightEye (Bethesda, MD, USA) RightEye System is a portable, all-in-one solution for vision-derived health screening, tracking eye movements and correlating them to health issues. The system is intended for primary care optometrists, rehabilitation facilities, professional sports teams, and the U.S. military. The system, which includes the RightEye EyeQ tests, reports, and training tools, has various applications, including:

• Functional Vision Screening, a vision test that helps quickly and objectively identify a host of functional vision issues that affect quality of life, with automatic recommendation of computer-based exercises patients can do at home.

• Reading Assessments - RightEye EyeQ tracks reading proficiency in real time, identifying hidden vision issues associated with learning difficulties.

• Sports Vision Assessment and Training – As the Sports Vision EyeQ test identifies opportunities to strengthen performance-related aspects of vision, the accompanying Sports Vision Trainer offers personalized exercises to athletes looking to improve coordination and reaction times.

• Brain Health - RightEye Brain Health EyeQ showcases the severity levels of vision skill problems and how this may relate to brain performance. It also provides computer-based vision exercises to help address oculomotor issues.

“RightEye is committed to providing innovative, proven eye-tracking solutions that empower doctors to differentiate and expand their practices while transforming the lives of their patients through improved health and wellness,” said Adam Gross, co-founder and CEO of RightEye. “It is the culmination of years of scientific research, product development and hard work. As we continue to pioneer the field of eye-tracking technology, we'll advance the science and discover new solutions and applications that will benefit patients and doctors alike.”

“The RightEye system has been an asset to my practice for its ability to help identify conditions that may have otherwise gone unnoticed,” said optometrist Adam Clarin, OD, of Clarin Eye Care (Miami, FL, USA). “The quick and easy-to-administer tests, coupled with objective and quantifiable reports, not only guide my decision on the type of treatment to recommend, but also makes it simple to explain issues to patients and parents.”

Related Links:
RightEye

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Cylindrical Water Scanning System
SunSCAN 3D
New
Transportation Stretcher
ES709

Print article

Channels

Surgical Techniques

view channel
Image: The stretchy hydrogel and a vial of liquid polymer (Photo courtesy of WPI)

New Class of Bioadhesives to Connect Human Tissues to Long-Term Medical Implants

Medical devices and human tissues differ significantly in their composition. While medical devices are primarily constructed from hard materials like metal and plastic, human tissue is soft and moist.... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.